Full Text
Patient-Reported Utility on Pembrolizumab (Pembro) and Ipilimumab (Ipi) among Ipi Naïve Patients with Advanced Melanoma

Abstract

Authors

K Stevinson W Zhou D Hille J Wang

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×